- JP-listed companies
- Dividends
(4893) Dividends
Market cap
¥6.4B
P/E ratio
Develops cancer immunotherapy treatments for solid tumors using proprietary PRIME technology that enhances immune cell activation and generates revenue through both in-house drug development and technology licensing.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of , the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- -
Dividend Policy
<p>We recognize returning profits to shareholders as an important management priority. However, our current policy is to prioritize upfront investment in research and development activities and not pay dividends at this time. In the future, we will consider distributing retained earnings while taking into account our business performance and financial condition. When we do implement dividends, our basic policy will be to pay dividends once per year at the fiscal year-end.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2026/02/13) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2026/02/13) | 0 | 0 | 0 | - |
| Forecast(2025/02/14) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2025/02/14) | 0 | 0 | 0 | - |
| Forecast(2024/02/13) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2024/02/13) | 0 | 0 | 0 | - |
| Forecast(2023/08/10) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2023/08/10) | 0 | 0 | 0 | - |